Immunohistochemistry (IHC) Market to Reach USD 7.4 Billion by 2034 at a 7.8% of CAGR

Fueled by rising cancer rates and improved diagnostics, the Immunohistochemistry (IHC) market is expected to reach USD 7.4 Billion by 2034 with a CAGR of 7.8%.

NEWARK, DE, UNITED STATES, February 5, 2025 /EINPresswire.com/ -- The global Immunohistochemistry (IHC) Market is projected to be valued at USD 3.5 billion in 2024 and is set to grow at a CAGR of 7.8%, reaching USD 7.4 billion by 2034. The expansion is fueled by advancements in multiplexing techniques, the integration of artificial intelligence (AI) with digital pathology, and the increasing role of IHC in precision medicine.

Recent developments in multiplexing technology have enhanced IHC’s ability to detect multiple biomarkers simultaneously, improving diagnostic accuracy. Additionally, AI-powered digital pathology is streamlining workflow efficiency and boosting reproducibility in immunohistochemical analysis, making IHC a preferred method in oncology, immunology, neuroscience, and infectious disease research.

𝐑𝐞𝐪𝐮𝐞𝐬𝐭 𝐚 𝐒𝐚𝐦𝐩𝐥𝐞 𝐑𝐞𝐩𝐨𝐫𝐭 𝐍𝐨𝐰 𝐭𝐨 𝐠𝐞𝐭 𝐏𝐫𝐞𝐦𝐢𝐮𝐦 𝐈𝐧𝐬𝐢𝐠𝐡𝐭𝐬: https://www.futuremarketinsights.com/report-sample#5245502d47422d3134383038

Companion diagnostics are playing a crucial role in the development of IHC-based immunotherapy trials, particularly in oncology. The demand for reliable and standardized IHC assays is also growing, as quality control measures become essential to ensure consistent and repeatable results.

𝐊𝐞𝐲 𝐓𝐚𝐤𝐞𝐚𝐰𝐚𝐲𝐬:

• Market Growth: The IHC market is expected to expand at a 7.8% CAGR, reaching USD 7.4 billion by 2034.
• AI & Digital Pathology: AI integration is enhancing workflow efficiency and diagnostic precision.
• Multiplexing & Biomarker Detection: Innovations allow for the simultaneous detection of multiple biomarkers, advancing precision medicine.
• Oncology & Beyond: IHC is expanding its therapeutic impact beyond oncology to immunology, neuroscience, and infectious diseases.

𝐀 𝐅𝐮𝐥𝐥 𝐑𝐞𝐩𝐨𝐫𝐭 𝐀𝐧𝐚𝐥𝐲𝐬𝐢𝐬 - https://www.futuremarketinsights.com/reports/immunohistochemistry-market

𝐊𝐞𝐲 𝐌𝐚𝐫𝐤𝐞𝐭 𝐓𝐫𝐞𝐧𝐝𝐬 𝐚𝐧𝐝 𝐇𝐢𝐠𝐡𝐥𝐢𝐠𝐡𝐭𝐬

• Advancements in Multiplexing Techniques: Recent developments in multiplexing allow for the simultaneous detection of multiple biomarkers, enhancing diagnostic capabilities and efficiency in immunohistochemistry applications.
• Integration of AI and Digital Pathology: The combination of artificial intelligence with digital pathology is improving workflow efficiency and diagnostic accuracy, facilitating more precise interpretations of immunohistochemical results.
• Companion Diagnostics in Oncology: The rise of companion diagnostic assays has spurred the development of immunohistochemistry-based trials for immunotherapy, particularly in oncology, thereby expanding the market's relevance in cancer treatment.
• Focus on Quality Control and Standardization: As the importance of quality control and standardization increases, immunohistochemistry assays are becoming more reliable and reproducible, which is critical for clinical applications.
• Broader Therapeutic Applications: The significance of immunohistochemistry extends beyond oncology, with growing applications in fields such as immunology, neuroscience, and infectious diseases.

𝐈𝐧-𝐕𝐢𝐭𝐫𝐨 𝐃𝐢𝐚𝐠𝐧𝐨𝐬𝐭𝐢𝐜𝐬 𝐌𝐚𝐫𝐤𝐞𝐭 𝐎𝐮𝐭𝐥𝐨𝐨𝐤: 𝐊𝐞𝐲 𝐏𝐥𝐚𝐲𝐞𝐫𝐬, 𝐂𝐨𝐧𝐬𝐮𝐦𝐞𝐫 𝐓𝐫𝐞𝐧𝐝𝐬, 𝐚𝐧𝐝 𝐅𝐨𝐫𝐞𝐜𝐚𝐬𝐭𝐬 𝐀𝐜𝐫𝐨𝐬𝐬 𝟐𝟎+ 𝐂𝐨𝐮𝐧𝐭𝐫𝐢𝐞𝐬 - https://www.futuremarketinsights.com/industry-analysis/in-vitro-diagnostics-devices

𝐇𝐨𝐰 𝐢𝐬 𝐚𝐫𝐭𝐢𝐟𝐢𝐜𝐢𝐚𝐥 𝐢𝐧𝐭𝐞𝐥𝐥𝐢𝐠𝐞𝐧𝐜𝐞 𝐭𝐫𝐚𝐧𝐬𝐟𝐨𝐫𝐦𝐢𝐧𝐠 𝐭𝐡𝐞 𝐢𝐦𝐦𝐮𝐧𝐨𝐡𝐢𝐬𝐭𝐨𝐜𝐡𝐞𝐦𝐢𝐬𝐭𝐫𝐲 𝐩𝐫𝐨𝐜𝐞𝐬𝐬?

Artificial intelligence (AI) is significantly transforming the immunohistochemistry (IHC) process by enhancing diagnostic accuracy, improving workflow efficiency, and expanding the capabilities of traditional methodologies. Here are the key ways AI is impacting IHC:

1. Automated Image Analysis
AI algorithms, particularly those utilizing deep learning (DL) and machine learning (ML), can analyze IHC-stained digital slides with remarkable precision. For example, studies have demonstrated that AI can effectively classify and quantify multiple cell types within a single tissue section, thereby improving the accuracy of diagnoses and enabling more detailed assessments of biomarkers.

2. Enhanced Diagnostic Accuracy
AI tools are being integrated into IHC workflows to assist pathologists in interpreting results more reliably. By using computer vision techniques, AI can predict marker expression from hematoxylin and eosin-stained images, allowing for a more nuanced understanding of tissue samples. This capability is particularly valuable in complex cases where human interpretation might be subjective or prone to error.

3. Efficiency in Workflow
The incorporation of AI into IHC processes streamlines workflows by automating time-consuming tasks such as image analysis and data management. This automation reduces the workload on pathologists and allows them to focus on more critical aspects of patient care, ultimately leading to faster turnaround times for diagnoses.

4. Companion Diagnostics
AI is playing a crucial role in the development of companion diagnostic assays, which are essential for personalized medicine approaches in oncology. By accurately assessing immunohistochemical markers, AI can help identify patients who are most likely to benefit from specific therapies, thus enhancing treatment outcomes.

5. Standardization and Quality Control
As the demand for reliable and repeatable IHC assays grows, AI contributes to standardization efforts by providing consistent analysis across different laboratories and settings. This consistency is vital for ensuring that diagnostic results are comparable and trustworthy.

6. Broader Applications Beyond Oncology
While IHC has traditionally been associated with cancer diagnostics, AI's capabilities are extending its applications into other areas such as immunology and infectious diseases. This broadening scope enhances the relevance of IHC in various medical fields, making it a versatile tool for researchers and clinicians alike.

𝐊𝐞𝐲 𝐂𝐨𝐦𝐩𝐚𝐧𝐢𝐞𝐬 𝐏𝐫𝐨𝐟𝐢𝐥𝐞𝐝

Thermo Fisher Scientific Inc.; F. Hoffmann-La Roche Ltd.; Merck KGaA; Danaher Corporation; Perkinelmer Inc.; Bio-Rad Laboratories Inc.; Cell Signaling Technology Inc.; Bio SB; Agilent Technologies Inc.; Abcam plc.

𝐈𝐦𝐦𝐮𝐧𝐨𝐡𝐢𝐬𝐭𝐨𝐜𝐡𝐞𝐦𝐢𝐬𝐭𝐫𝐲 (𝐈𝐇𝐂) - 𝐊𝐞𝐲 𝐒𝐞𝐠𝐦𝐞𝐧𝐭𝐬

By Product:
• Antibodies
o Primary Antibodies
o Secondary Antibodies
• Equipment
o Slide Staining System
o Tissue Microarrays
o Tissue Processing Systems
o Slide Scanners
o Others
• Reagents
o Histological stains
o Blocking Sera & Reagents
o Chromogenic Substrates
o Fixation Reagents
o Organic Solvents
o Proteolytic Enzymes
o Diluents
o Other Reagents
• Kits
By Application:
• Diagnostics
o Cancer
o Infectious Diseases
o Cardiovascular Diseases
o Autoimmune Diseases
o Diabetes Mellitus
o Nephrological Diseases
• Research
By End User:
• Hospitals & Diagnostic Laboratories
• Research Institutes
• Others
By Region:
• North America
• Latin America
• Western Europe
• Eastern Europe
• South Asia and Pacific
• East Asia
• Middle East and Africa

𝐄𝐱𝐩𝐥𝐨𝐫𝐞 𝐅𝐌𝐈'𝐬 𝐄𝐱𝐭𝐞𝐧𝐬𝐢𝐯𝐞 𝐂𝐨𝐯𝐞𝐫𝐚𝐠𝐞 𝐢𝐧 𝐭𝐡𝐞 𝐇𝐞𝐚𝐥𝐭𝐡𝐜𝐚𝐫𝐞 𝐃𝐨𝐦𝐚𝐢𝐧:

Fertility Pregnancy Rapid Test Kit Industry Outlook from 2025 to 2035 - https://www.futuremarketinsights.com/reports/fertility-and-pregnancy-rapid-tests-market

Platelet Function Test Industry Outlook from 2025 to 2035 - https://www.futuremarketinsights.com/reports/platelet-function-test-market

Zika Virus Testing Market Outlook from 2025 to 2035 - https://www.futuremarketinsights.com/reports/zika-virus-testing-market

Clinical Diagnostics Industry Outlook from 2025 to 2035 - https://www.futuremarketinsights.com/reports/clinical-diagnostics-market

At-Home Testing Industry Outlook from 2025 to 2035 - https://www.futuremarketinsights.com/reports/at-home-testing-market

Antimicrobial Susceptibility Testing Market Outlook from 2025 to 2035 - https://www.futuremarketinsights.com/reports/antibiotic-susceptibility-testing-market

Pancreatic Stone Protein Testing Market Outlook from 2024 to 2034 - https://www.futuremarketinsights.com/reports/pancreatic-stone-protein-testing-market

Nephelometry Market Outlook from 2024 to 2034 - https://www.futuremarketinsights.com/reports/nephelometry-market

Cancer Diagnostics Market Outlook from 2024 to 2034 – https://www.futuremarketinsights.com/reports/cancer-diagnostics-market

Ovulation Test Kit Market Outlook from 2024 to 2034 - https://www.futuremarketinsights.com/reports/ovulation-test-kit-market

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:

Future Market Insights Inc.

Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Ankush Nikam
Future Market Insights, Inc.
+ +91 90966 84197
email us here
Visit us on social media:
Facebook
X
LinkedIn
YouTube
Other